- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08.09. | Pfizer, BioNTech showcase new data supporting COVID booster | ||
| 08.09. | New Summit data clouds approval pathway in lung cancer | ||
| 08.09. | Rapport shares double on better-than-expected seizure drug data | ||
| 08.09. | A UK biotech takes aim at Parkinson's, ALS by drugging mitochondria | ||
| 08.09. | Driving precision oncology development: Integrated biomarker testing solutions that deliver impact | ||
| 08.09. | How sponsors are staying ahead in the obesity trial landscape | ||
| 08.09. | Harnessing the power of AI to detect ATTR-CM | ||
| 05.09. | FDA to publish CRLs in real time; PEPFAR to distribute Gilead's Yeztugo | ||
| 05.09. | Bravehart, a stealthy startup, looks to China to challenge Bristol Myers heart drug | ||
| 04.09. | At Senate hearing, lawmakers express dissatisfaction with RFK Jr.'s vaccine moves | ||
| 04.09. | Atlas Venture reels in $400M to grow its biotech startups | ||
| 04.09. | FDA outlines new review pathway for drugs treating ultra-rare diseases | ||
| 04.09. | Sanofi's touted eczema drug hits study goal, but data fall short of expectations | ||
| 04.09. | A drug discovery startup banks $150M for immune and obesity drugs | ||
| 03.09. | Biohaven's rare disease drug is 'ready to ship on Day 1' following FDA approval | ||
| 03.09. | Secretive startup Treeline unveils first clinical candidates, $200M in new funding | ||
| 03.09. | Wave shares sink on new study results for RNA editing drug | ||
| 03.09. | Over 1,000 HHS employees call on RFK Jr. to step down | ||
| 03.09. | Novartis licenses RNA drugs in deal with China-based Argo | ||
| 02.09. | Amgen to invest $600M in new US center; Sanofi drug for ITP approved | ||
| 02.09. | Novartis thinks Arrowhead brain drug can succeed where others couldn't | ||
| 02.09. | Ionis looks to expand use of lipid-lowering drug after trial hits goal | ||
| 02.09. | Startup Corsera Health aims to bring preventive heart medicine to the masses | ||
| 02.09. | Turning aspirational innovations into tangible impacts | ||
| 28.08. | CDC panel to discuss COVID, hepatitis B shots in meeting next month |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .